Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $8,348 - $9,465
-174 Reduced 0.6%
29,010 $1.57 Million
Q4 2023

Jan 29, 2024

SELL
$48.48 - $57.85 $1.31 Million - $1.56 Million
-27,000 Reduced 48.06%
29,184 $1.5 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $8,683 - $9,709
-150 Reduced 0.27%
56,184 $3.26 Million
Q1 2023

May 17, 2023

BUY
$65.71 - $74.53 $3.7 Million - $4.2 Million
56,334 New
56,334 $3.9 Million
Q2 2022

Aug 08, 2022

SELL
$72.62 - $79.98 $10.6 Million - $11.6 Million
-145,641 Closed
0 $0
Q1 2022

Apr 22, 2022

SELL
$61.48 - $73.72 $756,511 - $907,124
-12,305 Reduced 7.79%
145,641 $10.6 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $545,953 - $636,453
10,180 Added 6.89%
157,946 $9.85 Million
Q3 2021

Oct 25, 2021

BUY
$59.17 - $69.31 $40,827 - $47,823
690 Added 0.47%
147,766 $8.74 Million
Q2 2021

Aug 10, 2021

SELL
$61.91 - $67.42 $116,081 - $126,412
-1,875 Reduced 1.26%
147,076 $9.83 Million
Q1 2021

May 07, 2021

BUY
$59.34 - $66.74 $222,821 - $250,608
3,755 Added 2.59%
148,951 $9.4 Million
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $640,914 - $726,273
-11,100 Reduced 7.1%
145,196 $9.01 Million
Q3 2020

Oct 27, 2020

SELL
$57.43 - $63.64 $674,113 - $747,006
-11,738 Reduced 6.99%
156,296 $9.42 Million
Q2 2020

Aug 05, 2020

BUY
$54.82 - $64.09 $270,701 - $316,476
4,938 Added 3.03%
168,034 $9.88 Million
Q1 2020

Apr 29, 2020

SELL
$46.4 - $67.43 $153,120 - $222,519
-3,300 Reduced 1.98%
163,096 $9.09 Million
Q4 2019

Feb 04, 2020

BUY
$49.21 - $64.19 $3.03 Million - $3.95 Million
61,596 Added 58.77%
166,396 $10.7 Million
Q3 2019

Oct 17, 2019

SELL
$42.77 - $50.71 $34,216 - $40,568
-800 Reduced 0.76%
104,800 $5.31 Million
Q2 2019

Jul 23, 2019

BUY
$44.62 - $49.34 $4.52 Million - $5 Million
101,300 Added 2355.81%
105,600 $4.79 Million
Q1 2019

Apr 17, 2019

BUY
$45.12 - $53.8 $194,016 - $231,340
4,300 New
4,300 $205,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Harvey Capital Management Inc Portfolio

Follow Harvey Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvey Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Harvey Capital Management Inc with notifications on news.